Halogen Bonding in Nucleic Acid Complexes
Authors:
- 23 June 2017
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (21) , 8681-8690
Abstract
Halogen bonding (X-bonding) has attracted notable attention among noncovalent interactions. This highly directional attraction between a halogen atom and an electron donor has been exploited in knowledge-based drug design. A great deal of information has been gathered about X-bonds in protein–ligand complexes, as opposed to nucleic acid complexes. Here we provide a thorough analysis of nucleic acid complexes containing either halogenated building blocks or halogenated ligands. We analyzed close contacts between halogens and electron-rich moieties. The phosphate backbone oxygen is clearly the most common halogen acceptor. We identified 21 X-bonds within known structures of nucleic acid complexes. A vast majority of the X-bonds is formed by halogenated nucleobases, such as bromouridine, and feature excellent geometries. Noncovalent ligands have been found to form only interactions with suboptimal interaction geometries. Hence, the first X-bonded nucleic acid binder remains to be discovered.Keywords
All Related Versions
Funding Information
- Alexander von Humboldt-Stiftung
This publication has 84 references indexed in Scilit:
- The Halogen BondChemical Reviews, 2016
- Computational Tools To Model Halogen Bonds in Medicinal ChemistryJournal of Medicinal Chemistry, 2015
- Multiple evidence strands suggest that there may be as few as 19 000 human protein-coding genesHuman Molecular Genetics, 2014
- Halogen Bond: Its Role beyond Drug–Target Binding Affinity for Drug Discovery and DevelopmentJournal of Chemical Information and Modeling, 2014
- Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical BiologyJournal of Medicinal Chemistry, 2013
- Halogen bonding (X‐bonding): A biological perspectiveProtein Science, 2012
- Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug DesignCurrent Drug Targets, 2010
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Structures of helical junctions in nucleic acidsQuarterly Reviews of Biophysics, 2000
- The structure of the holliday junction, and its resolutionCell, 1988